Chad Ray

1.7k total citations · 1 hit paper
23 papers, 1.1k citations indexed

About

Chad Ray is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Chad Ray has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Immunology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Chad Ray's work include Biosimilars and Bioanalytical Methods (13 papers), Advanced Biosensing Techniques and Applications (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Chad Ray is often cited by papers focused on Biosimilars and Bioanalytical Methods (13 papers), Advanced Biosensing Techniques and Applications (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Chad Ray collaborates with scholars based in United States, Switzerland and Spain. Chad Ray's co-authors include Viswanath Devanarayan, Jean W. Lee, Peter J. O’Brien, Scott Fountain, Marie Green, Masood N. Khan, Yu Chen Barrett, John Allinson, John A. Wagner and Russell Weiner and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

Chad Ray

23 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement

2006 504 citations Jean W. Lee, Viswanath Devanarayan et al. Pharmaceutical Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chad Ray United States	14	558	453	208	143	105	23	1.1k
Wendell C. Smith United States	10	591 1.1×	716 1.6×	511 2.5×	178 1.2×	88 0.8×	13	1.2k
Binodh DeSilva United States	17	1.0k 1.9×	957 2.1×	669 3.2×	198 1.4×	120 1.1×	60	1.8k
Ekaterina Gibiansky United States	19	361 0.6×	302 0.7×	343 1.6×	267 1.9×	32 0.3×	42	1.3k
Mark Milton United States	18	516 0.9×	212 0.5×	210 1.0×	381 2.7×	43 0.4×	36	1.2k
Weirong Wang China	22	1.0k 1.8×	450 1.0×	571 2.7×	181 1.3×	78 0.7×	66	1.7k
Anthony J. Leathem United Kingdom	25	944 1.7×	431 1.0×	223 1.1×	285 2.0×	69 0.7×	53	1.7k
Simon Parry United Kingdom	16	545 1.0×	400 0.9×	112 0.5×	63 0.4×	53 0.5×	29	981
Richard Tacey United States	7	309 0.6×	367 0.8×	227 1.1×	74 0.5×	54 0.5×	7	602
Frank Staedtler Switzerland	21	781 1.4×	187 0.4×	36 0.2×	172 1.2×	88 0.8×	49	1.6k
Timothy K. Hart United States	19	903 1.6×	302 0.7×	103 0.5×	174 1.2×	429 4.1×	42	1.9k

Countries citing papers authored by Chad Ray

Since Specialization

Citations

This map shows the geographic impact of Chad Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad Ray more than expected).

Fields of papers citing papers by Chad Ray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad Ray. The network helps show where Chad Ray may publish in the future.

Co-authorship network of co-authors of Chad Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Chad Ray. A scholar is included among the top collaborators of Chad Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad Ray. Chad Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ray, Chad, et al.. (2020). A Flexible Multiplatform Bioanalytical Strategy for Measurement of Total Circulating Shed Target Receptors: Application to Soluble B Cell Maturation Antigen Levels in the Presence of a Bispecific Antibody Drug. Assay and Drug Development Technologies. 19(1). 17–26. 7 indexed citations

Mathews, Joel, Ni Yan, Connie Wang, et al.. (2020). Considerations for Soluble Protein Biomarker Blood Sample Matrix Selection. The AAPS Journal. 22(2). 38–38. 2 indexed citations

Arnold, Mark E., Brian Booth, Lindsay King, & Chad Ray. (2016). Workshop Report: Crystal City VI—Bioanalytical Method Validation for Biomarkers. The AAPS Journal. 18(6). 1366–1372. 43 indexed citations

Clark, Tracey, Phillip D. Yates, Alison Joyce, et al.. (2016). Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab Platform. The AAPS Journal. 18(5). 1300–1308. 11 indexed citations

Whalen, Pamela, et al.. (2012). Development and validation of an alpha fetoprotein immunoassay using Gyros technology. Journal of Pharmaceutical and Biomedical Analysis. 64-65. 8–15. 13 indexed citations

Zhong, Zhandong Don, Afshin Safavi, Darshana Jani, et al.. (2012). Ligand Binding Assays in the 21st Century Laboratory: Platforms. The AAPS Journal. 14(1). 113–118. 7 indexed citations

Nowatzke, William, et al.. (2011). Unique Challenges of Providing Bioanalytical Support for Biological Therapeutic Pharmacokinetic Programs. Bioanalysis. 3(5). 509–521. 25 indexed citations

Zhong, Zhandong Don, Martha Hokom, Chad Ray, et al.. (2010). Identification and inhibition of drug target interference in immunogenicity assays. Journal of Immunological Methods. 355(1-2). 21–28. 51 indexed citations

Ray, Chad, Lei Zhou, Jennifer Tsoi, et al.. (2010). A strategy for improving comparability across sites for ligand binding assays measuring therapeutic proteins. Journal of Pharmaceutical and Biomedical Analysis. 53(3). 729–734. 8 indexed citations

10.

Pandya, Kinnari, et al.. (2010). Strategies to minimize variability and bias associated with manual pipetting in ligand binding assays to assure data quality of protein therapeutic quantification. Journal of Pharmaceutical and Biomedical Analysis. 53(3). 623–630. 35 indexed citations

11.

Baselga, José, Mace L. Rothenberg, Josep Tabernero, et al.. (2008). TGF-β signalling-related markers in cancer patients with bone metastasis. Biomarkers. 13(2). 217–236. 52 indexed citations

12.

Lasbury, Mark E., et al.. (2007). Polyamine-mediated Apoptosis of Alveolar Macrophages during Pneumocystis Pneumonia. Journal of Biological Chemistry. 282(15). 11009–11020. 39 indexed citations

13.

Lasbury, Mark E., et al.. (2006). Suppression of Alveolar Macrophage Apoptosis Prolongs Survival of Rats and Mice with Pneumocystis Pneumonia. The Journal of Immunology. 176(11). 6443–6453. 40 indexed citations

14.

Ray, Chad, et al.. (2006). Transforming Growth Factor‐β Activation and Signaling in the Alveolar Environment during Pneumocystis Pneumonia. Journal of Eukaryotic Microbiology. 53(s1). S127–9. 3 indexed citations

15.

Lee, Jean W., Viswanath Devanarayan, Yu Chen Barrett, et al.. (2006). Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement. Pharmaceutical Research. 23(2). 312–328. 504 indexed citations breakdown →

16.

Lasbury, Mark E., et al.. (2006). Survival Pathway Signal Transduction is Reduced in Alveolar Macrophages during Pneumocystis Pneumonia. Journal of Eukaryotic Microbiology. 53(s1). S130–1. 2 indexed citations

17.

Green, Lisa J., Philip Marder, Chad Ray, et al.. (2006). Development and Validation of a Drug Activity Biomarker that Shows Target Inhibition in Cancer Patients Receiving Enzastaurin, a Novel Protein Kinase C-β Inhibitor. Clinical Cancer Research. 12(11). 3408–3415. 38 indexed citations

18.

Ray, Chad, Carmen M. Dumaual, Peter J. O’Brien, et al.. (2005). Optimization of analytical and pre-analytical variables associated with an ex vivo cytokine secretion assay. Journal of Pharmaceutical and Biomedical Analysis. 41(1). 189–195. 13 indexed citations

19.

Ray, Chad, Ronald R. Bowsher, Wendell C. Smith, et al.. (2004). Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. Journal of Pharmaceutical and Biomedical Analysis. 36(5). 1037–1044. 110 indexed citations

20.

Ray, Chad, et al.. (1996). Immunocytochemical analysis of the stage-specific distribution of collagen in the cuticle of Meloidogyne incognita. Fundamental & applied nematology. 19(1). 71–78. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact